Profil bibliographique

Masaya Murakami

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

54Publications signalées

238Citations signalées

4Affiliations récentes

Les institutions déclarées

Jikei University School of Medicine Fujisawa City Hospital Shizuoka General Hospital Fujieda Municipal General Hospital

Les domaines associés

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsBone health and treatments

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

The Impact of Preoperative Stent Placement and Stent Duration on Stone-Free Rate and Postoperative Fever

Yuji Yata, Sotaro Kayano, Tatsuya Shimomura, Toshihiro Yamamoto et autres

jp (code pays fourni par la source)

0 citations Research Square

2026 article OpenAlex

Stage-specific prognostic impact and recurrence patterns according to tumor location in upper tract urothelial carcinoma following radical nephroureterectomy: a propensity score-matched analysis

Yue Ogihara, Fumihiko Urabe, Masataka Kubo, Naoki Uchida et autres

jp (code pays fourni par la source)

0 citations Japanese Journal of Clinical Oncology

2026 article OpenAlex

IP78-10 REAL-WORLD OUTCOMES OF IO-BASED FIRST-LINE THERAPY IN METASTATIC RENAL CELL CARCINOMA PATIENTS ON HEMODIALYSIS

Hidetsugu Takahashi, Takafumi Yanagisawa, Maria Okamoto, Wataru Fukuokaya et autres

0 citations The Journal of Urology

2026 article OpenAlex

IP71-27 DEVELOPMENT OF PROGNOSTIC MODEL INCORPORATING TUMOR BURDEN IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: RESULTS OF A MULTICENTER COHORT STUDY

Hirokazu Kagawa, Wataru Fukuokaya, Takafumi Yanagisawa, Tatsushi Kawada et autres

0 citations The Journal of Urology

2026 article OpenAlex

IP78-12 NIVOLUMAB PLUS CABOZANTINIB VERSUS PEMBROLIZUMAB PLUS LENVATINIB FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY SCORE-MATCHED ANALYSIS OF JAPANESE MULTICENTER DATABASE

Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, Satoshi Katayama et autres

0 citations The Journal of Urology

2026 article OpenAlex

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features

Tatsuya Shimomura, Masaya Murakami, Kanako Kasai, Yu Imai et autres

jp (code pays fourni par la source)

0 citations The Prostate

2026 article OpenAlex

Real-world persistence of vibegron in patients aged ≥ 80 years with overactive bladder: a multicenter cohort study

Taro Igarashi, Yuto Nukariya, Shota Kawano, Mimu Ishikawa et autres

jp (code pays fourni par la source)

0 citations World Journal of Urology

2026 article OpenAlex

Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab

Yuzo Inaba, Fumihiko Urabe, Yu Imai, Juria Nakano et autres

jp (code pays fourni par la source)

0 citations Clinical Genitourinary Cancer

Accès ouvert 2026 article OpenAlex

A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium

Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, Satoshi Katayama et autres

jp, at (code pays fourni par la source)

1 citation Cancer Immunology Immunotherapy

Accès ouvert 2026 article OpenAlex

Clinical investigation of neuroendocrine differentiation in prostate cancer: A study focused on neuroendocrine tumor markers

Tatsuya Shimomura, Masaya Murakami, Kanako Kasai, Yu Imai et autres

jp (code pays fourni par la source)

1 citation Tumor Discovery

2026 article OpenAlex

Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy

Miyaka Umemori, Shun Sato, Fumihiko Urabe, Hirotaka Kondo et autres

jp (code pays fourni par la source)

0 citations Japanese Journal of Clinical Oncology

2025 article OpenAlex

Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumab

Fumihiko Urabe, Yu Imai, Kosuke Iwatani, Yuzo Inaba et autres

jp (code pays fourni par la source)

0 citations International Journal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.